To Study the Clinical Effect of Hyperbaric Oxygen Combined with Bu-tylphthalide on Atherosclerotic Ischemic Stroke
Objective To analyze the value of hyperbaric oxygen combined with butylphthalein in the treatment of ath-erosclerotic ischemic stroke patients.Methods A total of sixty-two patients with atherosclerotic ischemic stroke admit-ted to the Department of Neurology of Yantai Fushan District People's Hospital from October 2022 to October 2023 were non-randomly selected and divided into control group(n=31,butylphthalein treatment)and observation group(n=31,hyperbaric oxygen combined with butylphthalein treatment)according to different treatment methods.Compared the efficacy of the two groups.Results The score of National Institutes of Health Stroke Scale of the observation group was 11.21±4.34,lower than 18.78±5.45 of the control group,and the score of limb motor function was 79.89±5.65,higher than 66.56±6.76 of the control group,the differences were statistically significant(t=6.049,8.424,both P<0.05).The levels of endothelin and serum neuropeptide Y,tumor necrosis factor α,interleukin1β and neuron-specific enolase in observation group were lower than those in control group,and the differences were statistically significant(all P<0.05).Conclusion Hyperbaric oxygen combined with butylphthalein is effective in the treatment of atheroscle-rotic ischemic stroke patients,which can promote the rehabilitation of patients and improve nerve function.
NETL
NSTL
万方数据
